The individuals from the Board of Advisors will serve as consultants for IntelliStem Orthopaedic Innovations, Inc. These individuals are surgeons, engineers, and entrepreneurs who have extensive experience in licensing agreements, startup ventures, inventions, and medicine.
Jonathan P. Garino, MD
Dr. Garino received his BS and MD from Georgetown University, graduating Magna Cum Laude in both the undergraduate and medical schools. He completed his General Surgery internship at Presbyterian Hospital in New York, Orthopaedic Surgery residency at Columbia Presbyterian Hospital, and fellowship at the University of Pennsylvania. Dr. Garino is currently the Chief of Implant Service at Philadelphia’s Veterans Administration hospital, Director of the University of Pennsylvania Adult Reconstructive Fellowship Program, Director of the Presbyterian Medical Center Joint Reconstructive Center, Director of the Philadelphia Human Performance Lab at the Presbyterian Medical Center, an Associate Professor of Orthopaedic Surgery at the Hospital of the University of Pennsylvania School of Medicine, and an attending physician at the Department of Orthopaedic Surgery at the Hospital of the University of Pennsylvania. Dr. Garino has authored and published over 20 journal articles and has received the Orren Babb Award for Outstanding Senior Orthopaedic Resident Award, Jesse T. Nicholson Award for Outstanding Faculty Members, Pharmacology Award for his outstanding academic achievement in pharmacology, and has been recognized by Philadelphia Magazine’s “Top Doc” publication. He is involved in a number of orthopedic related research projects investigating bone tissue engineering and FDA-IDE trials for innovative total hip replacements.
Philip E. Bloomfield, Ph.D.
Philip E. Bloomfield, has been a Research Professor at Drexel University's Biomedical Engineering and Science Institute since 1992. Previous employment includes National Bureau of Standards (1956-57, 1974-76), University of PA Physics Dept. (1964-1970, 1988), City College of New York Physics Dept. (1970-73), Pennnwalt Corporation: Central Research Dept., King of Prussia, PA (1977-1987), Drexel University Materials Engineering Dept. (1989-1992) Dr. Bloomfield is the holder of eight U.S. Patents and has authored over seventy published papers. While at NBS he developed a fuzing concept utilizing piezoelectric PVDF that led to an Annual Army R & D Award (1976). At the Pennwalt Corp. Dr. Bloomfield was responsible for formulating, directing, and executing research on materials, devices, and other applications in electroactive polymers that were being optimized for their dielectric, piezoelectric, and pyroelectric properties. At Drexel University Dr. Bloomfield carries out dielectric and polarization studies on ferroelectric materials and research and development of infrared detectors and ultrasonic. transducers. Dr. Bloomfield is a member of the IEEE Ultrasonics, Ferroelectrics, and Frequency Control Society's Committee on Ferroelectrics and IEEE Ferroelectrics Standards Committee and at the University of PA's Center for Sensor Technologies he participates in the physical sensor research program.
Paul Ducheyne, PhD
Paul Ducheyne is Professor of Bioengineering, Professor of Orthopaedic Surgery Research and Professor of Biomaterials in Dentistry at the University of Pennsylvania, Philadelphia. He also is the Director of the Center for Bioactive Materials and Tissue Engineering at this University. He has authored more than 280 papers and chapters in a variety of international journals and books, and he has edited 10 books. Dr. Ducheyne obtained his Ph.D. on a thesis entitled “Metallic Orthopaedic Implants with a Porous Coating” in 1976. With fellowships from the National Institutes of Health (International Postdoctoral Fellowship) and the Belgian American Educational Foundation (Honorary Fellowship), he performed postdoctoral research at the University of Florida (the laboratory of Bioceramics and the department of Orthopaedic Surgery). Since 1990, all technologies coming from his lab were withheld from licensing to existing companies. These patents formed the wealth of technology at the basis of Orthovita (NASDAQ: VITA), a corporation founded in 1992 with offices in the Philadelphia area and operations in the USA and Belgium. Paul Ducheyne attracted Orthovita’s top level management, and he served as Chairman of the Board until 1999 and Director until 2003. In 2001 – 2002, Paul Ducheyne was on leave from academia and directed the start-up phase of Gentis, Inc., Philadelphia.
Jeffrey Babin, MBA
Jeffrey Babin has more than 20 years of experience developing business strategies for emerging companies as well as Fortune 500 clients including AT&T, Hewlett-Packard, IBM, and Intel. Jeffrey is a Managing Director and founder of Antiphony Partners, LLC, a strategic consulting firm that specializes in helping emerging companies create sustainable value. Prior to Antiphony, he served as CEO of Corporate Technology Ventures, a company he founded and grew into one of the nation’s premier medical software publishing companies. Jeffrey serves as a Lecturer in Engineering Entrepreneurship in the School of Engineering and Applied Science (SEAS) at the University of Pennsylvania, and as Associate Director of the National University of Singapore's College in BioValley (a cooperative educational exchange program with SEAS). Jeffrey was a Lecturer in Entrepreneurship for the Wharton School of the University of Pennsylvania and currently holds an appointment in Marketing. He is the India Country Manager for the Wharton Global Consulting Practicum. He is a member of the Greater Philadelphia Venture Group's Education and Outreach Committee, serves on the Wharton Venture Initiation Program Oversight Committee, and is a frequent lecturer on emerging business strategies nationally. Jeffrey earned a B.A. degree from the University of Pennsylvania and an MBA from The Wharton School.
Barry Libin, DDS, MSD, MS
Barry M. Libin, DDS, MSD, MS (Management) is Founder and Chairman of BML MEDRECORDS ALERT, an Internet based electronic medical records company, and serves as President and CEO of Nanopolymer Corporation, a privately held drug delivery company. Dr. Libin is past Chairman and CEO of BML Pharmaceuticals, a research and development firm in cancer therapy. He practiced periodontics in New York City, and was on the staff of New York Hospital-Cornell Medical School. Dr. Libin received his DDS degree from New York University, Masters in Dentistry (Periodontics and Oral Medicine) from NYU, and MS in Management and Policy from the Harriman School at the University at Stony Brook.
Jeffrey S. Yablon MBA, CHE
Jeffrey Yablon is the Founder and Chief Operating Officer at PharmaScan Clinical Trials, a specialty clinical research organization focusing on medical imaging. He is also a Principal at Yablon Management Consulting where he provides strategic, operational and business development consultation to companies involved in drug and clinical development. He is an advisor to a private equity firm focused on life sciences. Yablon is a Course Director and Instructor at Stony Brook University, Center for Biotechnology. Previously Yablon was COO at Icon laboratories a Division of ICON PLC. He also held management positions at Abbott Laboratories, TAP Pharmaceuticals and Digene. Yablon holds an MBA (executive program) from Fairleigh Dickenson University and was awarded a Certified Healthcare Executive (CHE) distinction from the American College of Healthcare Executives.